Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
Submitted by
admin
on October 19, 2023 - 10:03am
Source:
Reuters
News Tags:
Roche
earnings
Vabysmo
Headline:
Roche's Q3 sales down 3% on currency headwinds, drop in COVID sales
snippet:
Vabysmo eye drug beats consensus again
Quarterly sales in line with market expectations
CEO says in no rush to pursue external deals, partnerships
Shares decline on disappointment over confirmed guidance
Do Not Allow Advertisers to Use My Personal information
